{"id":"1a980e76-4ebe-54bf-bbc4-ad9e0e7e6add","stable_key":"f8641d02-8413-5bd8-92e9-62ad49286e81:asa-salicylate-activates-ampk","predicate":"activates","statement":"At concentrations reached in plasma after administration of salsalate or of aspirin at high doses, salicylate activates AMP-activated protein kinase by binding at the same site as the synthetic activator A-769662 to cause allosteric activation and inhibition of dephosphorylation of the activating phosphorylation site threonine-172, and in knockout mice the effects of salicylate to increase fat utilisation and to lower plasma fatty acids in vivo were lost.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"80792576-e14c-5d5b-908d-aa293036a9a7","mechanism_event_label":"The old plant compound switches on the cell’s energy sensor directly, at doses far above a daily aspirin.","subject":{"id":"5739797a-3699-591b-95fd-f8b80e612713","slug":"salicylate","display_name":"Salicylate / salicylic acid","entity_type_key":"small_molecule"},"object":{"id":"8128eec0-61cc-51ef-8d4e-5ec9678e8dfa","slug":"ampk-complexes","display_name":"AMP-activated protein kinase complexes","entity_type_key":"protein_family"},"evidence_count":1,"mechanism_event":{"id":"80792576-e14c-5d5b-908d-aa293036a9a7","stable_key":"f8641d02-8413-5bd8-92e9-62ad49286e81:asa-salicylate-activates-ampk-event","event_type":"biochemical_relationship","label":"The old plant compound switches on the cell’s energy sensor directly, at doses far above a daily aspirin.","description":"At concentrations reached in plasma after administration of salsalate or of aspirin at high doses, salicylate activates AMP-activated protein kinase by binding at the same site as the synthetic activator A-769662 to cause allosteric activation and inhibition of dephosphorylation of the activating phosphorylation site threonine-172, and in knockout mice the effects of salicylate to increase fat utilisation and to lower plasma fatty acids in vivo were lost.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"7a03a04c-3996-55c4-b43c-dea5855655fd","slug":"a-769662","display_name":"A-769662, a synthetic AMPK activator","entity_type_key":"chemical_species"},"role":"shared_binding_site","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"b336d2e5-2ddc-58e9-8be9-1b5ff98e765f","slug":"ampk-thr172","display_name":"Phosphorylation of AMP-activated protein kinase at threonine 172","entity_type_key":"protein_state"},"role":"protected_phosphosite","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"5fd5a2dd-2567-551f-ba13-58dc13a292bf","slug":"ampk-knockout-mouse","display_name":"AMP-activated protein kinase knockout mouse genotype","entity_type_key":"protein_state"},"role":"test_genotype","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"276517bb-c62f-52b2-a642-0eec37697c30","slug":"salsalate","display_name":"Salsalate","entity_type_key":"drug"},"role":"delivering_drug","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"3ef9ff5b-7c1c-5dca-b613-098fe935fa30","slug":"fat-utilisation","display_name":"Whole-body fat utilisation","entity_type_key":"cellular_process"},"role":"downstream_process","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""},{"entity":{"id":"8ad04bcb-2d59-5196-9376-cf6a1c80f433","slug":"plasma-fatty-acids","display_name":"Plasma fatty acid concentration","entity_type_key":"cellular_process"},"role":"lowered_measure","stoichiometry":null,"state_label":"","sequence_order":5,"notes":""},{"entity":{"id":"e025e167-c634-505c-b1ae-99faa263f6dd","slug":"prkaa1","display_name":"Human AMPK catalytic subunit alpha 1 / PRKAA1","entity_type_key":"protein"},"role":"catalytic_subunit","stoichiometry":null,"state_label":"","sequence_order":6,"notes":""},{"entity":{"id":"5739797a-3699-591b-95fd-f8b80e612713","slug":"salicylate","display_name":"Salicylate / salicylic acid","entity_type_key":"small_molecule"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":7,"notes":""},{"entity":{"id":"8128eec0-61cc-51ef-8d4e-5ec9678e8dfa","slug":"ampk-complexes","display_name":"AMP-activated protein kinase complexes","entity_type_key":"protein_family"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":8,"notes":""}]},"contexts":[{"dimension":"availability_state","value_text":"biomarker_context","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null},{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/aspirin-research/22517326.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"1a48863bf252421416f67d62acb18c9f44f170075c5aff6f775eba14bba2b1b4\", \"start_char\": 0, \"end_char\": 887, \"text_sha256\": \"1a48863bf252421416f67d62acb18c9f44f170075c5aff6f775eba14bba2b1b4\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Allosteric activation and dephosphorylation assays with AMP-activated protein kinase knockout mice","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"Salicylate at concentrations reached in plasma after salsalate or high-dose aspirin, against the synthetic activator A-769662","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"The knockout arm ties the whole-animal effect to the kinase. The concentrations are those of high-dose salicylate therapy, not of antiplatelet aspirin, which the authors state explicitly.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Aspirin research collection; topical membership is not evidence of a direct clinical effect, and aspirin is recorded separately from salicylate, the metabolite it becomes.","comparator":null,"unit":null,"notes":"","entity":{"slug":"aspirin","display_name":"Aspirin / acetylsalicylic acid","entity_type_key":"drug"}},{"dimension":"organism","value_text":"Human enzyme and mouse","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"The old plant compound switches on the cell’s energy sensor directly, at doses far above a daily aspirin.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[asa-p22517326] The ancient drug salicylate directly activates AMP-activated protein kinase. (2012). https://pubmed.ncbi.nlm.nih.gov/22517326/ DOI: 10.1126/science.1215327","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"AMP-activated protein kinase","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"trigger_kind","value_text":"biomarker_context","comparator":null,"unit":null,"notes":"Imported condition classification; unverified.","entity":null}],"evidence":[{"id":"bf73e92a-2bdb-50ef-b387-9c3111dd8abe","evidence_kind":"source_excerpt","locator":"Lines 494-505","start_line":494,"end_line":505,"excerpt":"### asa-salicylate-activates-ampk\nAt concentrations reached in plasma after administration of salsalate or of aspirin at high doses, salicylate activates AMP-activated protein kinase by binding at the same site as the synthetic activator A-769662 to cause allosteric activation and inhibition of dephosphorylation of the activating phosphorylation site threonine-172, and in knockout mice the effects of salicylate to increase fat utilisation and to lower plasma fatty acids in vivo were lost.\nCondition category: biomarker_context\nnutrient_topic: Aspirin research collection; topical membership is not evidence of a direct clinical effect, and aspirin is recorded separately from salicylate, the metabolite it becomes.\nplain_language: The old plant compound switches on the cell’s energy sensor directly, at doses far above a daily aspirin.\norganism: Human enzyme and mouse\ntissue_or_cell_type: AMP-activated protein kinase\nexperimental_model: Allosteric activation and dephosphorylation assays with AMP-activated protein kinase knockout mice\nlimitations: The knockout arm ties the whole-animal effect to the kinase. The concentrations are those of high-dose salicylate therapy, not of antiplatelet aspirin, which the authors state explicitly.\nexposure: Salicylate at concentrations reached in plasma after salsalate or high-dose aspirin, against the synthetic activator A-769662\nevidence_span: {\"source_cache\": \"artifacts/aspirin-research/22517326.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"1a48863bf252421416f67d62acb18c9f44f170075c5aff6f775eba14bba2b1b4\", \"start_char\": 0, \"end_char\": 887, \"text_sha256\": \"1a48863bf252421416f67d62acb18c9f44f170075c5aff6f775eba14bba2b1b4\"}\n[asa-p22517326] The ancient drug salicylate directly activates AMP-activated protein kinase. (2012). https://pubmed.ncbi.nlm.nih.gov/22517326/ DOI: 10.1126/science.1215327","model_system":"Allosteric activation and dephosphorylation assays with AMP-activated protein kinase knockout mice","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [asa-p22517326] The ancient drug salicylate directly activates AMP-activated protein kinase. (2012). https://pubmed.ncbi.nlm.nih.gov/22517326/ DOI: 10.1126/science.1215327","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"712cf519-cd27-5a8b-9e2f-961a98d7a27e","stable_key":"import-f8641d02-8413-5bd8-92e9-62ad49286e81","title":"Aspirin: the serine it acetylates, the enzyme that acetylation creates, the dose that separates platelet from vessel wall, and the metabolite that is a different drug (2026-09-22)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"93dd4343051c131e40d4fc3c95a978cd65478c13dcdb3f2d42507c49b09cb647","revision_id":"694e8ee7-49ca-5e6c-b58b-8ba8f82c2ad8","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}